Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for thera...
Main Authors: | Clarissa S. Santoso, Zhaorong Li, Jaice T. Rottenberg, Xing Liu, Vivian X. Shen, Juan I. Fuxman Bass |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.673485/full |
Similar Items
-
Prospective approach to manage COVID-19-related cytokine storm; an updated review on current concepts
by: Mohaddeseh Bahmani, et al.
Published: (2021-01-01) -
A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm
by: Mohd Rehan, et al.
Published: (2021-06-01) -
Cytokine release syndrome
by: Alexander Shimabukuro-Vornhagen, et al.
Published: (2018-06-01) -
MECHANISMS OF CYTOKINE STORM DEVELOPMENT IN COVID-19 AND NEW POTENTIAL TARGETS OF PHARMACOTHERAPY
by: V. I. Petrov, et al.
Published: (2021-05-01) -
Immunotherapy Summary for Cytokine Storm in COVID-19
by: Yaqun Li, et al.
Published: (2021-09-01)